Analyst Observations
Published: September 30, 2025
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: CRWV, HCA, & NYT.

 

CRWV CoreWeave, Inc. Class A ($137.01) - Computers - CRWV moved higher Tuesday to break a double top at $140 before reaching $142 intraday. This 3 for 5'er moved to a positive trend in May but still sits on a sell signal against the market and its peers, highlighting the mixed technical picture. Still, Tuesday's improvement is a positive sign in the near-term. Initial support can be seen at $120. Further overhead resistance may be seen initially at $148.
HCA HCA Healthcare Inc. ($428.92) - Healthcare - HCA inched higher to break a double top at $424, marking its second consecutive buy signal and a new all-time high. The 5 for 5'er reversed back into a positive trend last month. Additionally, the stock ranks in the top quartile of the healthcare sector matrix. Long exposure can be made here. Initial support is at $388, with additional support at $332.
NYT The New York Times Company ($57.36) - Media - Despite the sell signal today, NYT moves to a possible point of support on its default chart. $57 marks the middle of the trading band and old resistance from this summer, as well as highs from both 2021 and 2024. With that in mind, those looking for focused exposure to more traditional communication services names could look to take advantage of an attractive risk/reward profile. Towards the downside, watch the bullish support line at $52.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-{ENDYEAR} Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright